PHARMALIPON TURBO

General Information

PHARMALIPON TURBO is a certified and officially registered medicinal product in Ukraine. It is an antioxidant that has a beneficial effect on the nervous system. In modern pharmaceutical practice and medicine, this substance is used for the treatment of pain and paresthesia associated with diabetic polyneuropathy. The therapeutic effectiveness of the product has been enhanced through the use of innovative formulations that improve the solubility and intestinal absorption of thioctic acid.

Today, PHARMALIPON TURBO is widely used in the management of neurological disorders, including diabetic polyneuropathy, which is characterized by reduced sensitivity of peripheral nerve endings. Scientific research is also being conducted on its use in patients with other conditions, including those in the field of gastroenterology.

The key advantage of PHARMALIPON TURBO is its ready-to-use solution supplied in a 50 mL vial.

Composition

Thioctic acid – 1 mL of solution contains 12 mg of thioctic (alpha-lipoic) acid, equivalent to 600 mg per vial.

Excipients: meglumine, macrogol 300, water for injection.

Indications

Paresthesia associated with diabetic polyneuropathy.

Directions for Use

The product is administered directly from the vial (without dilution) as an intravenous infusion in adults at a dose of 600 mg per day (1 vial).

The vials should be kept in their original carton packaging until use, as alpha-lipoic acid is sensitive to light.